Organogenesis Holdings Inc. (ORGO)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$0.85
-5.48%
Mkt Cap $127.56M
Analyst Ratings
Buy
0
Hold
1
Sell
0
Price Target (6 analysts)
$2.50
Range $2.00 – $3.00
Implied Upside
+193.1%
Consensus $2.50 vs current $0.85